1–1 of 1 result for RBP4
Eighteen-Month Results From the Phase 1b-2 Study of Tinlarebant in Adolescent Subjects with Stargardt Disease
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Annual Meeting Talks
2023